Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats
- PMID: 27928694
- DOI: 10.1007/s11011-016-9929-4
Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats
Abstract
Dietary compounds like flavonoids may offer protection against neurodegeneration. Huntington's disease (HD) is a neurodegenerative disorder characterized by symptoms like chorea and dementia. 3-Nitropropionic acid (3-NP), a Succinate dehydrogenase (SDH) inhibitor produces behavioral, biochemical and histological changes in the striatum, mimics HD in animals and humans. The present study was designed to examine the protective activity of Rutin (RT), a primary flavonoid from citrus fruits, green tea on 3-NP induced experimental model of HD in rats. Rats were pretreated with Rutin, a potent antioxidant (25 and 50 mg/kg b.w.) orally prior to the intraperitoneally (i.p.) administration of 3-NP (10 mg/kg b.w.) for 14 days. Behavioral assessments were carried out on 5th, 10th and 15th day after 3-NP treatment. Body weight, biochemical and histological studies were analyzed on 15th day. Systemic administration of 3-NP significantly reduced the body weight, locomotor activities (Rota rod, Open field test), memory (Morris water maze) and antioxidants such as Glutathione (GSH) levels, activities of Superoxide dismutase (SOD), Catalase (CAT), Glutathione peroxidase (GPx), Glutathione-S-transferase (GST), Glutathione reductase (GR). 3-NP also produces striatal damage by increased the levels of lipid peroxides, nitrite, Glial Fibrillary Acidic Protein (GFAP) and activity of Acetylcholine esterase (AchE). Thus, Rutin treatment of 25 and 50 mg/kg b.w. has significantly restored all the biochemical, behavioral and histological alterations caused by the 3-NP through its antioxidant activity. The findings of our study indicates that Rutin may have an important role in protecting the striatum from oxidative/nitrosative insults caused by 3-NP. These results suggest that RT might be a drug of choice to treat HD.
Keywords: 3-nitropropionic acid; Antioxidants; GFAP; Neurobehavior; Rutin.
Similar articles
-
Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum.Int J Neurosci. 2014 Sep;124(9):673-84. doi: 10.3109/00207454.2013.872642. Epub 2014 Jan 23. Int J Neurosci. 2014. PMID: 24325390
-
Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity.Life Sci. 2009 Nov 4;85(19-20):711-8. doi: 10.1016/j.lfs.2009.10.001. Epub 2009 Oct 12. Life Sci. 2009. PMID: 19822156
-
Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.Biomed Pharmacother. 2018 Sep;105:1254-1268. doi: 10.1016/j.biopha.2018.06.079. Epub 2018 Jun 22. Biomed Pharmacother. 2018. PMID: 30021362
-
A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease.Mol Neurobiol. 2024 Mar;61(3):1237-1270. doi: 10.1007/s12035-023-03604-4. Epub 2023 Sep 12. Mol Neurobiol. 2024. PMID: 37698833 Review.
-
3-Nitropropionic acid animal model and Huntington's disease.Neurosci Biobehav Rev. 1997 May;21(3):289-93. doi: 10.1016/s0149-7634(96)00027-9. Neurosci Biobehav Rev. 1997. PMID: 9168265 Review.
Cited by
-
Azilsartan Attenuates 3-Nitropropinoic Acid-Induced Neurotoxicity in Rats: The Role of IĸB/NF-ĸB and KEAP1/Nrf2 Signaling Pathways.Neurochem Res. 2024 Apr;49(4):1017-1033. doi: 10.1007/s11064-023-04083-8. Epub 2024 Jan 7. Neurochem Res. 2024. PMID: 38184805 Free PMC article.
-
Rutin and Selenium Co-administration Reverse 3-Nitropropionic Acid-Induced Neurochemical and Molecular Impairments in a Mouse Model of Huntington's Disease.Neurotox Res. 2020 Jan;37(1):77-92. doi: 10.1007/s12640-019-00086-y. Epub 2019 Jul 22. Neurotox Res. 2020. PMID: 31332714
-
Impaired Redox Signaling in Huntington's Disease: Therapeutic Implications.Front Mol Neurosci. 2019 Mar 19;12:68. doi: 10.3389/fnmol.2019.00068. eCollection 2019. Front Mol Neurosci. 2019. PMID: 30941013 Free PMC article. Review.
-
Neuroinflammation in Huntington's Disease: A Starring Role for Astrocyte and Microglia.Curr Neuropharmacol. 2022;20(6):1116-1143. doi: 10.2174/1570159X19666211201094608. Curr Neuropharmacol. 2022. PMID: 34852742 Free PMC article. Review.
-
Ruta graveolens as a potential source of neuroactive compounds to promote and restore neural functions.J Tradit Complement Med. 2020 Jun 4;10(3):309-314. doi: 10.1016/j.jtcme.2020.05.002. eCollection 2020 May. J Tradit Complement Med. 2020. PMID: 32670826 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous